Answers are grounded in this paper and cite their sources.
Oral in situ melanoma (OISM) is considered an extremely rare tumour, but with a more favourable prognosis than its invasive counterpart. In this report, we describe a patient with OISM diagnosed back in 2011, who has been undergoing clinical follow‐up ever since, and, to our knowledge, represents the longest and best‐documented case described in the literature. In April 2011, a 77‐year‐old Caucasian man presented for detailed evaluation of detected by the patient in November 2010. He had no relevant medical history. On physical examination, multiple dark asymptomatic macular lesions were seen on the vestibular gingiva of the right maxilla and the left lateral incisor, left canine, premolars and first molar, with hyperpigmented macular lesions on the palatal gingiva (Fig. 1a,b). Clinical presentation on (a) buccal gingiva and (b) palatal gingiva; (c) surgical site appearance in March 2017, showing no signs of disease. The clinical diagnosis was melanoma, thus a field mapping biopsy was taken. Samples were stained with haematoxylin and eosin, and also stained immunohistochemically with antibodies to S‐100, HMB45, p16 and MIB‐1. Two samples excised from the left canine and premolar gingiva showed an atypical cell proliferation, as well as strong positivity to HBM45 and S‐100, confirming the diagnosis. Furthermore, the neoplastic process appeared to be confined to the intraepithelial limits (Fig. 2a,b). (a) Biopsy specimen showing atypical cells (haematoxylin and eosin; original magnification × 100); (b) immunohistochemistry showed that the samples were positive for HBM45 and S‐100 (original magnification × 200). Therefore, a final diagnosis of melanoma in situ of the gingiva was made. The patient underwent hemimaxillectomy from first right premolar to second left molar in May 2011, without complication. The OISM was fully excised, with radial margins of 5 mm. In July 2011, histological evaluation of the surgical specimen confirmed tumour‐free margins. In the subsequent months, a definitive prosthesis was fabricated; this was fitted in December 2011, and the patient was educated accordingly. Between 2012 and 2016, seven pigmented lesions were detected on the lip, the tongue tip, the buccal mucosa and the maxilla itself, in the general location of the previous surgery, with a mean diameter of no more than 2–3 mm. Swift evaluation and excision of these new lesions has always led to a diagnosis of melanotic macules, based on findings of increased pigmentation in the basal cell layer or the lamina propria (and in one case in both), with no sign of atypia. At his current age of 83 years old, after 6 years of follow‐up, the patient appears to be in good health; the last follow‐up visit, performed in March 2017, showed no signs of local or systemic recurrence (Fig. 1c). According to the literature, OISM is an exceedingly rare subgroup of oral malignant melanoma; ours is only the 12th case reported to date (Table 1). Based on the little information available, OISM seems to show a predilection for men, with a mean age of onset of 53 years (range 16–77 years). Of the 12 reported cases of OISM, 9 had lesions either in the gingiva or in the palate. Surgical excision was the gold‐standard treatment, with local and distant recurrence in 25% (2/8) of these cases, and a mean of 26 months of follow‐up. Owing to its rarity, there are no surgical guidelines available for OISM. Considering its potential recurrence, close post‐surgical follow‐up is imperative. Clinical features, treatment, outcome, follow‐up of twelve OISM, including our case Clinical features, treatment, outcome, follow‐up of twelve OISM, including our case Conflict of interest: the authors declare that they have no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Carbone et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: